NEW YORK , Aug. 22, 2024 /PRNewswire/ -- The global sinus dilation devices market size is estimated to grow by USD 1.50 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of almost 8.09% during the forecast period. High prevalence of chronic sinusitis is driving market growth, with a trend towards technological advances in sinusitis treatment.
However, presence of alternative treatments poses a challenge. Key market players include Accurate Surgical and Scientific Instruments Corp., Aetna Inc.
, B.Braun SE, Dalent LLC, EMOS Technology GmbH, ESC Medicams, InnAccel Technologies Pvt. Ltd.
, Johnson and Johnson Services Inc., KARL STORZ SE and Co. KG, Medtronic Plc, Meril Life Sciences Pvt.
Ltd., Olympus Corp., Optim LLC, SinuSys Corp.
, Sklar Surgical Instruments, Smith and Nephew plc, Stryker Corp., Summit Medical LLC, and TE Connectivity Ltd..
Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report Market Driver The sinus surgery industry has seen significant technological advancements since the 1950s, starting with Functional Endoscopic Sinus Surgery (FESS) and image-guided surgery. FESS uses an endoscope in the nasal cavity to open up passageways below the eyes for better drainage. Image-guided surgery is a more detailed version of FESS, utilizing advanced camera and telescopic technologies like CT scanners and MRIs.
The Caldwell-Luc method is used for patients with sinus abn.